CF
CORZ

Cantor Fitzgerald’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Cantor Fitzgerald’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-65,000
Closed -$712K – 510
2021
Q4 		$712K Buy
+65,000
New +$767K 0.05% 220

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Cantor Fitzgerald's CORZ Position: Q1 2022 in Review

Cantor Fitzgerald sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2022, closing a stake of 65,000 shares — an estimated $712K sold.

Cantor Fitzgerald first reported a position in CORZ in Q4 2021 and held it in 1 quarter. The position peaked at $712K in Q4 2021. 91 funds tracked by Wall St. Rank hold CORZ as of Q1 2022.

  • Cantor Fitzgerald reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Cantor Fitzgerald sold 65,000 Core Scientific, Inc. Common Stock shares in Q1 2022, an estimated $712K.
  • Cantor Fitzgerald first reported a position in Core Scientific, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Cantor Fitzgerald's Core Scientific, Inc. Common Stock position peaked at $712K in Q4 2021.
  • 91 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2022.

Based on Cantor Fitzgerald's 13F filing for Q1 2022, filed 16 May 2022.